- 面议
起订量：
肿瘤测量仪
- 型号
该企业相似产品
上海玉研科学仪器有限公司是一家专业为生物、医学、药物研发等科研领域提供科学仪器和技术服务的公司。我们着力引进和开发应用成熟、性能先进的实验设备和实验方法，为科学研究和实验室建设提供有效、合理的解决方案。
玉研仪器专注于生理、药理、毒理等动物实验和研究的相关领域，为客户提供动物麻醉与辅助呼吸、生理信号检测与记录、动物给药与暴露染毒、呼吸功能测量与肺功能研究、代谢与缺血缺氧研究、疼痛与炎症研究、小动物行为学研究、神经科学研究、小动物活体成像、生化检验、动物手术与辅助设备、动物手术器械等多方面的科学仪器产品和定制化服务。
玉研仪器致力于打造动物科研仪器领域的百科全书！
经营理念：诚信经营、实干兴邦、积极进取、回报社会
服务理念：客户至上、主动服务、快速响应、解决问题
我们的使命：提供优质产品和高效服务，助力科研，成就科研
详细信息
动物肿瘤测量仪，非常适合对大鼠小鼠等动物的皮下肿瘤进行快速测量、分析，精确测量动物肿瘤并对肿瘤信息存档与跟踪。
主要技术参数：
· 测量范围：0-25mm肿瘤尺寸：20*20*20mm
· 3D测量精确度：<0.3mm
· 图像捕捉时间：0.1s
· 接口：USB 2.0
· 相机：1600*1200 像素（2MP）
· 工作距离：50mm
动物肿瘤测量分析仪的主要特点：
· 手持式成像装置，实现立体成像；
· 适合测量不同尺寸的肿瘤；
· 方便使用：触屏式电脑，操作方便；
· 内置软件，自动计算肿瘤尺寸，跟踪整个实验进展。
· 快速，高效，保证了高通量和可靠测量；
· 全自动测量跟踪系统；
· 实时数据分析与处理。
部分用户：
Hunter College, CUNY
Vanderbilt University Medical Center
Hainan Medical University
Howard Hughes Medical Institute
Memorial Sloan Kettering Cancer Center
Cancer Center Amsterdam
GlaxoSmithKline
Imec
K.U.Leuven
Neuro-Electronics Research Flanders
Pepric
PharmaVize
reMYND
University Ghent
SEPS Pharma
Vlaams Instituut voor Biotechnologie
University Antwerp
ThromboGenics
Janssen Pharmaceutica
City University of Hong Kong
参考文献：
1.Adams EJ, Karthaus WR, Hoover E, et al. FOXA1 mutations alter pioneering activity, differentiation and prostate cancer phenotypes. Nature. 2019;571(7765):408-412. doi:10.1038/s41586-019-1318-9.
2.Zhang Z, Zhou C, Li X, et al. Loss of CHD1 Promotes Heterogeneous Mechanisms of Resistance to AR-Targeted Therapy via Chromatin Dysregulation. Cancer Cell. 2020;37(4):584-598.e11. doi:10.1016/j.ccell.2020.03.001.
3.Santich BH, Park JA, Tran H, et al. Interdomain spacing and spatial configuration drive the potency of IgG-[L]-scFv T cell bispecific antibodies. Sci Transl Med. 2020;12(534):eaax1315. doi:10.1126/scitranslmed.aax1315.
4.Park JA, Xu H, Cheung, I, et al. Abstract B38: Tetravalent bispecific antibodies specific for HER2 and disialoganglioside GD2 to engage polyclonal T cells for osteosarcoma therapy. Cancer Res. 2018;78(19),B38.doi:10.1158/1538-7445.PEDCA17-B38.
5.Wu CF, Wu CY, Lin CF, et al. The anticancer effects of cyanidin 3-O-glucoside combined with 5-fluorouracil on lung large-cell carcinoma in nude mice. Biomed Pharmacother. 2022;151:113128. doi:10.1016/j.biopha.2022.113128.
6.Wang L, Hoseini SS, Xu H, et al. Silencing Fc Domains in T cell-Engaging Bispecific Antibodies Improves T-cell Trafficking and Antitumor Potency. Cancer Immunol Res. 2019;7(12):2013-2024. doi:10.1158/2326-6066.CIR-19-0121.
7.Grochowska A, Statkiewicz M, Kulecka M, et al. Evidence supporting the oncogenic role of BAZ1B in colorectal cancer. Am J Cancer Res. 2022;12(10):4751-4763.
8.Hoseini SS, Vadlamudi M, Espinosa-Cotton M, et al. T cell engaging bispecific antibodies targeting CD33 IgV and IgC domains for the treatment of acute myeloid leukemia. J Immunother Cancer. 2021;9(5):e002509. doi:10.1136/jitc-2021-002509.
9.Beguin E, Gray MD, Logan KA, et al. Magnetic microbubble mediated chemo-sonodynamic therapy using a combined magnetic-acoustic device. J Control Release. 2020;317:23-33. doi:10.1016/j.jconrel.2019.11.013.
10.Mao N, Gao D, Hu W, et al. Aberrant Expression of ERG Promotes Resistance to Combined PI3K and AR Pathway Inhibition through Maintenance of AR Target Genes. Mol Cancer Ther. 2019;18(9):1577-1586. doi:10.1158/1535-7163.MCT-18-1386.
11.Wu Z, Guo HF, Xu H, et al. Development of a Tetravalent Anti-GPA33/Anti-CD3 Bispecific Antibody for Colorectal Cancers. Mol Cancer Ther. 2018;17(10):2164-2175. doi:10.1158/1535-7163.MCT-18-0026.
12.Poty S, Mandleywala K, O'Neill E, et al. 89Zr-PET imaging of DNA double-strａnd breaks for the early monitoring of response following α- and β-particle radioimmunotherapy in a mouse model of pancreatic ductal adenocarcinoma. Theranostics. 2020;10(13):5802-5814. doi:10.7150/thno.44772.
13.Hoseini SS, Guo H, Wu Z, et al. A potent tetravalent T-cell-engaging bispecific antibody against CD33 in acute myeloid leukemia. Blood Adv. 2018;2(11):1250-1258. doi:10.1182/bloodadvances.2017014373.
14.Zhang Z, Karthaus WR, Lee YS, et al. Tumor Microenvironment-Derived NRG1 Promotes Antiandrogen Resistance in Prostate Cancer. Cancer Cell. 2020;38(2):279-296.e9. doi:10.1016/j.ccell.2020.06.005.
15.Poty S, Carter LM, Mandleywala K, et al. Leveraging Bioorthogonal Click Chemistry to Improve 225Ac-Radioimmunotherapy of Pancreatic Ductal Adenocarcinoma. Clin Cancer Res. 2019;25(2):868-880. doi:10.1158/1078-0432.CCR-18-1650.
：，
：
yuyanbio
：yuyanbio